An honest broker is an entity that keeps sets of private information but distributes parts of those sets to other entities who should not have access to the entire set. Honest brokers often work in clinical research with biological specimens; in that case, donors of specimens allow researchers to do research on those specimens, but typically want their specimen de-identified by having protected health information separated from it. The honest broker would keep both the specimen and associated protected health information, but only allow researchers to have access to the specimen without the protected health information.
YouTube Encyclopedic
-
1/3Views:1 229194 527845
-
An Honest Look At Trading Stocks
-
Broker Review: Robinhood Trading App
-
My view on Interactive Brokers tick data and market latency issues
Transcription
Characteristics
Honest brokers are typically appointed to a research project by an institutional review board.[1] They provide data from clinical and research sources for research use only and in accordance with policies that prohibit re-identification.[2]
Organizations conducting breast cancer research have identified access to biological specimens as a top priority, and therefore honest broker systems are key to research because they increase access to specimens.[3]
Diplomacy
In diplomacy an "honest broker" is an entity (individual or organisation) that is accepted by all sides in a negotiation as impartial. Neutrality does not equal an absence of interest; rather, the interest of the honest broker lies in a solution, without preference for either party involved in the conflict.[citation needed]
German Chancellor Otto von Bismarck was the first to use the term (applied to himself) in connection with the 1878 Congress of Berlin.[4]
References
- ^ Auray-Blais, C.; Patenaude, J. (2006). "A biobank management model applicable to biomedical research". BMC Medical Ethics. 7: 4. doi:10.1186/1472-6939-7-4. PMC 1475589. PMID 16600040.
- ^ Dhir, R.; Patel, A. A.; Winters, S.; Bisceglia, M.; Swanson, D.; Aamodt, R.; Becich, M. J. (2008). "A multidisciplinary approach to honest broker services for tissue banks and clinical data". Cancer. 113 (7): 1705–1715. doi:10.1002/cncr.23768. PMC 2745185. PMID 18683217.
- ^ Taube, S. E.; Barr, P.; Livolsi, V.; Pinn, V. W. (1998). "Ensuring the Availability of Specimens for Research". The Breast Journal. 4 (5): 391. doi:10.1046/j.1524-4741.1998.450391.x. S2CID 71197746.
- ^ The Washington Institute for Near East Policy: The United States as an Honest Broker - The Washington Institute for Near East Policy, accessdate: May 30, 2018
This page was last edited on 23 May 2024, at 16:01